Antimicrobial resistance (AMR) is one of the most significant and immediate threats to health in Australia and globally. We are working on harnessing new technologies such as artificial intelligence and next-generation sequencing and to improve the diagnosis, treatment and prevention of AMR infections.
The specific aims of this project are:
1. Rapidly identify AMR and predict treatment responses through use of genomics and machine learning in a clinical context.